REC-2615

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameREC-2615
Drug Alias NameREC-2615Rec-15/2615
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1b adrenergic receptor antagonists
TargetsAlpha-1b adrenergic receptor
Therapy Area/IndicationsSexual Dysfunctions, Psychological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRecordati
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati Spa
Active IndicationsN/A
Inactive IndicationsSexual Dysfunctions, Psychological

Other Information

ATC CodeN/A
Related LinksN/A